• Johnson & Johnson will present new vision-care data at ARVO 2026 in Denver, with 17 posters or oral sessions scheduled for this week.
• Preclinical work on TECNIS PureSee and TECNIS Odyssey intraocular lenses indicated performance held up under conditions intended to reflect typical real-world implant positioning.
• Separate testing and simulations tied peripheral optics to functional vision, suggesting a new monofocal peripheral-vision lens concept could improve peripheral performance while preserving central vision, with potential benefits for tasks such as driving.
• In myopia control, research to be presented showed children wearing ACUVUE Abiliti 1-Day had less progression over 24 months versus a real-world comparison group, supporting longer-duration use claims outside US market availability.
• Contact-lens materials analysis introduced a moisture-retention index intended to help differentiate on-eye performance potential across commercial soft lenses.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief on May 04, 2026, and is solely responsible for the information contained therein.